Fasciola hepatica is a liver parasite of mammals and it results in poor welfare outcomes and economic losses in ruminants.
While faecal egg count is the test most commonly used for diagnosis, it does not indicate presence of migrating immature stages. Serological techniques increase sensitivity at all stages of the liver fluke infection. The aim of this study was to compare four commercially available ELISA tests for the diagnosis of F. hepatica. For this purpose, we tested three sample types; (i) known F. hepatica status sera from an experimental infection for the comparison of sensitivities and specificities, (ii) sera from pre- and post-flukicide-treated (albendazole, closantel, nitroxynil and triclabendazole) beef cattle to contrast the differences of seropositivity before and after treatment, and (iii) bulk tank milk samples from dairy herds sampled during high and low F.
hepatica exposure periods for assessing seasonal variations with the four tests available. Samples were tested using ELISA kits supplied by four manufacturers (Ildana Biotech, IDEXX, Svanova, and Bio-X). Samples were analysed simultaneously and in duplicate.In the control population Ildana, IDEXX and Bio-X presented 100% sensitivity (Se) and specificity (Sp), Svanovir presented a Se of 59% and a Sp of 96%.
In flukicide-treated beef cattle, kits highlighted decreasing antibody levels 90 days post-treatment in variable degrees. Finally, bulk milk showed a significant decrease in ELISA value between high and low fluke exposure periods with all tests studied.Se and Sp found in the present study, confirm that Ildana, IDEXX and Bio-X are accurate for the detection of F. hepatica exposure in Irish cattle. Svanovir Se and Sp in this population, indicate that a larger study is necessary to confirm this test characteristic in Irish herds.
4-Arm PEG-MA |
abx085177-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 610.8 |
|
4-Arm PEG-MA |
abx085177-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 610.8 |
|
4-Arm PEG-MA |
abx085177-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 1228.8 |
|
4-Arm PEG-MA |
abx085177-5kDa1g |
Abbexa |
5 kDa; 1 g |
EUR 577.2 |
|
N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
T18435-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
T18435-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
T18435-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
T18435-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
T18435-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
Cy3.5-PEG-Mal,2K |
FL077022-2K-500mg |
Biochempeg |
500mg |
EUR 652.8 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Cy3.5-PEG-Mal,3.4K |
FL077022-3.4K-500mg |
Biochempeg |
500mg |
EUR 652.8 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Cy3.5-PEG-Mal,5K |
FL077022-5K-500mg |
Biochempeg |
500mg |
EUR 652.8 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Cy3.5-PEG-Mal |
abx085322-10kDa500mg |
Abbexa |
10 kDa; 500 mg |
EUR 961.2 |
|
Cy3.5-PEG-Mal |
abx085322-2kDa500mg |
Abbexa |
2 kDa; 500 mg |
EUR 961.2 |
|
Cy3.5-PEG-Mal |
abx085322-34kDa500mg |
Abbexa |
3.4 kDa; 500 mg |
EUR 961.2 |
|
Cy3.5-PEG-Mal |
abx085322-5kDa500mg |
Abbexa |
5 kDa; 500 mg |
EUR 961.2 |
|
PCL(12K)-PEG-Mal |
abx085326-10kDa500mg |
Abbexa |
10 kDa; 500 mg |
EUR 1144.8 |
|
PCL(12K)-PEG-Mal |
abx085326-2kDa500mg |
Abbexa |
2 kDa; 500 mg |
EUR 1144.8 |
|
PCL(12K)-PEG-Mal |
abx085326-5kDa500mg |
Abbexa |
5 kDa; 500 mg |
EUR 1144.8 |
|
PLGA(5K)-PEG-Mal |
abx085332-34kDa500mg |
Abbexa |
3.4 kDa; 500 mg |
EUR 1245.6 |
|
PLGA(50:50)(8K)-PEG-Mal |
abx085344-05kDa500mg |
Abbexa |
0.5 kDa; 500 mg |
EUR 1296 |
|
PLGA(50:50)(8K)-PEG-Mal |
abx085344-1kDa500mg |
Abbexa |
1 kDa; 500 mg |
EUR 1446 |
|
PLGA(50:50)(8K)-PEG-Mal |
abx085344-2kDa500mg |
Abbexa |
2 kDa; 500 mg |
EUR 1479.6 |
|
PLGA(50:50)(8K)-PEG-Mal |
abx085344-34kDa500mg |
Abbexa |
3.4 kDa; 500 mg |
EUR 1479.6 |
|
4-Arm PEG-Mal |
abx085089-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 477.6 |
|
4-Arm PEG-Mal |
abx085089-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 477.6 |
|
4-Arm PEG-Mal |
abx085089-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 844.8 |
|
4-Arm PEG-Mal |
abx085089-5kDa1g |
Abbexa |
5 kDa; 1 g |
EUR 444 |
|
8-Arm PEG-Mal |
abx085119-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 444 |
|
8-Arm PEG-Mal |
abx085119-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 444 |
|
8-Arm PEG-Mal |
abx085119-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 961.2 |
|
8-Arm PEG-Mal |
abx085119-40kDa1g |
Abbexa |
40 kDa; 1 g |
EUR 444 |
|
PCL(12K)-PEG-Mal,2K |
HE062022-2K-500mg |
Biochempeg |
500mg |
EUR 800.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PCL(12K)-PEG-Mal,5K |
HE062022-5K-500mg |
Biochempeg |
500mg |
EUR 800.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(5K)-PEG-MAL,2K |
HE085022-2K-500mg |
Biochempeg |
500mg |
EUR 873.6 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(5K)-PEG-MAL,3.4K |
HE085022-3.4K-500mg |
Biochempeg |
500mg |
EUR 873.6 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(5K)-PEG-MAL,5K |
HE085022-5K-500mg |
Biochempeg |
500mg |
EUR 873.6 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(50:50)?8K?-PEG-Mal,1K |
HE086022-1K-500mg |
Biochempeg |
500mg |
EUR 800.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(50:50)?8K?-PEG-Mal,2K |
HE086022-2K-500mg |
Biochempeg |
500mg |
EUR 770.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(50:50)?8K?-PEG-Mal,3.4K |
HE086022-3.4K-500mg |
Biochempeg |
500mg |
EUR 770.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(50:50)?8K?-PEG-Mal,500 |
HE086022-500-500mg |
Biochempeg |
500mg |
EUR 918 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(50:50)?8K?-PEG-Mal,5K |
HE086022-5K-500mg |
Biochempeg |
500mg |
EUR 770.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
4-Arm PEG-Mal |
abx085089-100l |
Abbexa |
100 µl |
EUR 300 |
4-Arm PEG-Mal |
abx085089-1ml |
Abbexa |
1 ml |
EUR 312.5 |
4-Arm PEG-Mal |
abx085089-200l |
Abbexa |
200 µl |
EUR 312.5 |
8-Arm PEG-Mal |
abx085119-100l |
Abbexa |
100 µl |
EUR 300 |
8-Arm PEG-Mal |
abx085119-1ml |
Abbexa |
1 ml |
EUR 300 |
8-Arm PEG-Mal |
abx085119-200l |
Abbexa |
200 µl |
EUR 300 |
Cy3.5-PEG-Mal |
abx085322-100l |
Abbexa |
100 µl |
EUR 662.5 |
Cy3.5-PEG-Mal |
abx085322-1ml |
Abbexa |
1 ml |
EUR 662.5 |
Cy3.5-PEG-Mal |
abx085322-200l |
Abbexa |
200 µl |
EUR 662.5 |
Cy3.5-PEG-Mal,10K |
FL077022-10K-500mg |
Biochempeg |
500mg |
EUR 652.8 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Cy3.5-PEG-Mal,20K |
FL077022-20K-500mg |
Biochempeg |
500mg |
EUR 652.8 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PCL(12K)-PEG-Mal,10K |
HE062022-10K-500mg |
Biochempeg |
500mg |
EUR 800.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PCL(12K)-PEG-Mal,20K |
HE062022-20K-500mg |
Biochempeg |
500mg |
EUR 800.4 |
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(12K)-PEG-MAL,2K |
33-HE088022-2K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(12K)-PEG-MAL,3.4K |
33-HE088022-3.4K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(12K)-PEG-MAL,5K |
33-HE088022-5K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(18K)-PEG-MAL,3.4K |
33-HE118022-3.4K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
PLGA(30K)-PEG-Mal |
abx085340-100l |
Abbexa |
100 µl |
EUR 625 |
PLGA(30K)-PEG-Mal |
abx085340-1ml |
Abbexa |
1 ml |
Ask for price |
PLGA(30K)-PEG-Mal |
abx085340-200l |
Abbexa |
200 µl |
EUR 1025 |
PEG3-methylamine |
T16457-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: PEG3-methylamine |
PEG3-methylamine |
T16457-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: PEG3-methylamine |
PEG3-methylamine |
T16457-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: PEG3-methylamine |
PEG3-methylamine |
T16457-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: PEG3-methylamine |
Anti-TACSTD2 (clone 7E6)-PEG6-MMAD ADC |
ADC-W-292 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone 7E6) conjugated via a PEG6 linker to MMAD |
Anti-TACSTD2 (clone C16)-PEG6-MMAD ADC |
ADC-W-538 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone C16) conjugated via a PEG6 linker to MMAD |
4-Arm PEG-Methacrylate |
abx085177-100l |
Abbexa |
100 µl |
EUR 362.5 |
4-Arm PEG-Methacrylate |
abx085177-1ml |
Abbexa |
1 ml |
EUR 362.5 |
4-Arm PEG-Methacrylate |
abx085177-200l |
Abbexa |
200 µl |
EUR 362.5 |
Anti-MUC1 (clone huC242)-PEG4Mal-DM1 ADC |
ADC-W-313 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-MUC1 monoclonal antibody (clone huC242) conjugated via a PEG4Mal linker to a DM1 |
Anti-TNFRSF17 (clone 2A1)-PEG4-Mal-DM4 ADC |
ADC-W-121 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone 2A1) conjugated via a PEG4-Mal linker to DM4 |
Anti-TNFRSF17 (clone 1E1)-PEG4-Mal-DM4 ADC |
ADC-W-125 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-TNFRSF17 monoclonal antibody (clone 1E1) conjugated via a PEG4-Mal linker to DM4 |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
T16248-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
T16248-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
T16248-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
T16248-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
T16248-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester) |
Polyethylene glycol monomethacrylate (PEGMA 200) |
16712-100 |
Polysciences Europe GmbH |
100g |
EUR 332 |
Description: 25736-86-1 |
Polyethylene glycol monomethacrylate (PEGMA 400) |
16713-100 |
Polysciences Europe GmbH |
100g |
EUR 111 |
Description: 25736-86-1 |
Polyethylene glycol monomethacrylate (PEGMA 440) |
24890-1000 |
Polysciences Europe GmbH |
1kg |
EUR 420 |
Description: 25736-86-1 |
AzoDye-2 PEG10 Alkyne |
2435 |
AAT Bioquest |
1 mg |
EUR 155 |
Description: AzoDye-2 PEG10 alkyne is an excellent building block for labeling azide-containing molecules. |
AzoDye-2 PEG10 Alkyne |
2435-1mg |
AAT Bioquest |
1 mg |
EUR 151 |
|
Description: AzoDye-2 PEG10 alkyne is an excellent building block for labeling azide-containing molecules. |
4-Methylumbelliferyl 2-Acetamido-2-deoxy-alpha-D-galactopyranoside PEG2000 Ether |
M333510 |
Toronto Research Chemicals |
250mg |
EUR 19000 |
|
In post-treatment use, Bio-X showed a consistent and significant decrease of ELISA value in all groups treated, denoting to be a reliable tool for assessing treatment effect at 90 days post-treatment. Finally, all tests showed to be a reliable tool for the F. hepatica monitoring of high and low exposure seasons, using bulk tank milk samples.